How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?

Background. Hypertension is considered to be the most common condition in the general population. It is the most important risk factor for premature deaths in the world. Treatment compliance at every stage is a condition for successful antihypertensive therapy, and improving the effectiveness of tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Bartosz Uchmanowicz, Anna Chudiak, Izabella Uchmanowicz, Grzegorz Mazur
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2019/5245184
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552084663173120
author Bartosz Uchmanowicz
Anna Chudiak
Izabella Uchmanowicz
Grzegorz Mazur
author_facet Bartosz Uchmanowicz
Anna Chudiak
Izabella Uchmanowicz
Grzegorz Mazur
author_sort Bartosz Uchmanowicz
collection DOAJ
description Background. Hypertension is considered to be the most common condition in the general population. It is the most important risk factor for premature deaths in the world. Treatment compliance at every stage is a condition for successful antihypertensive therapy, and improving the effectiveness of treatment is a major goal in preventing cardiovascular incidents. Treatment noncompliance and lack of cooperation stem from numerous problems of older age, including frailty syndrome. Objective. To evaluate the effect of frailty syndrome on treatment compliance in older patients with hypertension. Methods. The study sample consisted of 160 patients (91 women, 69 men) with hypertension aged 65 to 78 (mean = 72.09, SD = 7.98 years), hospitalized at the University Clinical Hospital due to exacerbation of disease symptoms. Standardised research tools were used: the Tilburg Frailty Indicator questionnaire and the questionnaire for the assessment of treatment compliance in patients with hypertension, the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Results. Frailty syndrome was diagnosed in 65.62% of patients: 35.62% with mild, 29.38% with moderate, and 0.62% with severe frailty. The treatment compliance was 36.14%. The prevalence of the FS and its three components (physical, psychological, social) significantly affected (p <0.05) the global score of the Hill-Bone Compliance to High Blood Pressure Therapy Scale and all subscales: “reduced sodium intake”, “appointment keeping”, and “antihypertensive medication taking”. Conclusions. The coexistence of frailty syndrome has a negative impact on the compliance of older patients with hypertension. Diagnosis of frailty and of the associated difficulties in adhering to treatment may allow for targeting the older patients with a poorer prognosis and at risk of complications from untreated or undertreated hypertension and for planning interventions to improve hypertension control.
format Article
id doaj-art-73f3b6beb08b4a28bcc99afb7ba01161
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-73f3b6beb08b4a28bcc99afb7ba011612025-02-03T05:59:38ZengWileyInternational Journal of Hypertension2090-03842090-03922019-01-01201910.1155/2019/52451845245184How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?Bartosz Uchmanowicz0Anna Chudiak1Izabella Uchmanowicz2Grzegorz Mazur3Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, PolandDepartment of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, PolandDepartment of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, PolandDepartment and Clinic of Internal and Occupational Diseases and Hypertension, Jan Mikulicz-Radecki University Teaching Hospital in Wroclaw, 213 Borowska Street, 50-556 Wrocław, PolandBackground. Hypertension is considered to be the most common condition in the general population. It is the most important risk factor for premature deaths in the world. Treatment compliance at every stage is a condition for successful antihypertensive therapy, and improving the effectiveness of treatment is a major goal in preventing cardiovascular incidents. Treatment noncompliance and lack of cooperation stem from numerous problems of older age, including frailty syndrome. Objective. To evaluate the effect of frailty syndrome on treatment compliance in older patients with hypertension. Methods. The study sample consisted of 160 patients (91 women, 69 men) with hypertension aged 65 to 78 (mean = 72.09, SD = 7.98 years), hospitalized at the University Clinical Hospital due to exacerbation of disease symptoms. Standardised research tools were used: the Tilburg Frailty Indicator questionnaire and the questionnaire for the assessment of treatment compliance in patients with hypertension, the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Results. Frailty syndrome was diagnosed in 65.62% of patients: 35.62% with mild, 29.38% with moderate, and 0.62% with severe frailty. The treatment compliance was 36.14%. The prevalence of the FS and its three components (physical, psychological, social) significantly affected (p <0.05) the global score of the Hill-Bone Compliance to High Blood Pressure Therapy Scale and all subscales: “reduced sodium intake”, “appointment keeping”, and “antihypertensive medication taking”. Conclusions. The coexistence of frailty syndrome has a negative impact on the compliance of older patients with hypertension. Diagnosis of frailty and of the associated difficulties in adhering to treatment may allow for targeting the older patients with a poorer prognosis and at risk of complications from untreated or undertreated hypertension and for planning interventions to improve hypertension control.http://dx.doi.org/10.1155/2019/5245184
spellingShingle Bartosz Uchmanowicz
Anna Chudiak
Izabella Uchmanowicz
Grzegorz Mazur
How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
International Journal of Hypertension
title How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
title_full How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
title_fullStr How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
title_full_unstemmed How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
title_short How May Coexisting Frailty Influence Adherence to Treatment in Elderly Hypertensive Patients?
title_sort how may coexisting frailty influence adherence to treatment in elderly hypertensive patients
url http://dx.doi.org/10.1155/2019/5245184
work_keys_str_mv AT bartoszuchmanowicz howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients
AT annachudiak howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients
AT izabellauchmanowicz howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients
AT grzegorzmazur howmaycoexistingfrailtyinfluenceadherencetotreatmentinelderlyhypertensivepatients